'Smart stent' detects narrowing of arteries

June 19, 2018, University of British Columbia
The device uses medical-grade stainless steel and looks similar to most commercial stents. Credit: University of British Columbia

For every three individuals who have had a stent implanted to keep clogged arteries open and prevent a heart attack, at least one will experience restenosis—the renewed narrowing of the artery due to plaque buildup or scarring—which can lead to additional complications.

Now, a team led by UBC electrical and computer engineering professor Kenichi Takahata has developed a type of "smart stent" that monitors even subtle changes in the flow of blood through the artery, detecting the narrowing in its earliest stages and making early diagnosis and treatment possible.

"We modified a stent to function as a miniature antenna and added a special micro-sensor that we developed to continuously track blood flow. The data can then be sent wirelessly to an external reader, providing constantly updated information on the artery's condition," said Takahata.

The device uses medical-grade stainless steel and looks similar to most commercial . Researchers say it's the first angioplasty-ready smart stent—it can be implanted using current medical procedures without modifications.

Research collaborator Dr. York Hsiang, a UBC professor of surgery and a vascular surgeon at Vancouver General Hospital, noted that monitoring for restenosis is critical in managing heart disease.

"X-rays such as CT or diagnostic angiograms, which are the standard tools for diagnosis, can be impractical or inconvenient for the patient," said Hsiang. "Putting a smart stent in place of a standard one can enable physicians to monitor their patient's health more easily and offer treatment, if needed, in a timely manner."

The device prototype was successfully tested in the lab and in a swine model. Takahata, who holds patents for the technology, says his team is planning to establish industry partnerships to further refine the device, put it through clinical trials and eventually commercialize it.

The research is described in the May issue of Advanced Science and featured on its front cover.

Explore further: Red wine proves good for the heart (again)

More information: Xing Chen et al, Medical Implants: Enabling Angioplasty-Ready "Smart" Stents to Detect In-Stent Restenosis and Occlusion (Adv. Sci. 5/2018), Advanced Science (2018). DOI: 10.1002/advs.201870027

Related Stories

Red wine proves good for the heart (again)

February 1, 2018
Antioxidant compounds found in red wine are advancing the treatment of heart disease—the leading cause of death for both men and women in the U.S.

Survival rates lower for heart transplant patients whose arteries reclose after stenting

June 18, 2012
Heart transplant patients are notorious for developing an aggressive form of coronary artery disease that can often result in heart failure, death or the need for repeat transplantation. The condition can also have a negative ...

Drug-eluting stent approved for peripheral arterial disease

November 16, 2012
(HealthDay)—The Zilver PTX Drug-Eluting Peripheral Stent has been approved by the U.S. Food and Drug Administration to treat peripheral arterial disease of the femoropopliteal artery.

UH Case Medical Center cardiologists first to implant Abbott 'Absorb' Stent in Midwest

July 9, 2016
University Hospitals Case Medical Center is among the first in the country - and the first in Ohio - to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent. The Absorb stent works exactly as its traditional ...

Recommended for you

Non-coding genetic variant could improve key vascular functions

November 15, 2018
Atherosclerotic disease, the slow and silent hardening and narrowing of the arteries, is a leading cause of mortality worldwide. It is responsible for more than 15 million deaths each year, including an estimated 610,000 ...

Study of two tribes sheds light on role of Western-influenced diet in blood pressure

November 14, 2018
A South American tribe living in near-total isolation with no Western dietary influences showed no increase in average blood pressure from age one to age 60, according to a study led by researchers at Johns Hopkins Bloomberg ...

Heart failure patients shouldn't stop meds even if condition improves: study

November 13, 2018
(HealthDay)—There's bad news for heart failure patients with dilated cardiomyopathy who'd like to stop taking their meds.

Bypass beats stents for diabetics with heart trouble: study

November 13, 2018
(HealthDay)—People with both diabetes and multiple clogged heart arteries live longer if they undergo bypass surgery rather than have their blood vessels reopened with stents, according to follow-up results from a landmark ...

Kawasaki disease: One disease, multiple triggers

November 12, 2018
Researchers at University of California San Diego School of Medicine, Scripps Institution of Oceanography, and international collaborators have evidence that Kawasaki Disease (KD) does not have a single cause. By studying ...

New treatment significantly reduces cardiovascular events when combined with statins

November 12, 2018
Statins are the most commonly used treatment for cardiovascular disease. Despite reducing certain risk factors, if triglyceride levels remain high with use of statins, there is still a significant risk for heart attack, stroke ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.